• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.

作者信息

Hansen C E, Larsen N E

出版信息

Psychopharmacologia. 1974 Jun 18;37(1):31-6. doi: 10.1007/BF00426680.

DOI:10.1007/BF00426680
PMID:4415024
Abstract
摘要

相似文献

1
Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.人全血中的奋乃静浓度。一项使用不同给药形式的抗精神病治疗期间的初步研究。
Psychopharmacologia. 1974 Jun 18;37(1):31-6. doi: 10.1007/BF00426680.
2
[Therapy control of perphenazine. 2. Clinical aspects].[奋乃静的治疗控制。2. 临床方面]
Ugeskr Laeger. 1991 Aug 19;153(34):2339-43.
3
[Therapy control of perphenazine in paranoid conditions. 1. Organizational aspects].[奋乃静在偏执状态中的治疗控制。1. 组织方面]
Ugeskr Laeger. 1991 Aug 19;153(34):2336-9.
4
[Clinical experiences with perphenazine enanthate].[庚酸奋乃静的临床经验]
Nord Psykiatr Tidsskr. 1971;25(4):371-4. doi: 10.3109/08039487109094685.
5
Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice.临床实践中监测奋乃静血药浓度的治疗优势。
Psychopharmacology (Berl). 1985;87(1):16-9. doi: 10.1007/BF00431770.
6
Determination of perphenazine and its sulphoxide metabolite in human plasma after therapeutic doses by gas chromatography.治疗剂量后气相色谱法测定人血浆中奋乃静及其亚砜代谢物
J Chromatogr. 1975 Jun 18;109(2):259-64. doi: 10.1016/s0021-9673(01)91797-2.
7
Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.连续口服治疗期间奋乃静及其亚砜代谢物的血浆浓度。
Psychopharmacology (Berl). 1977 Jul 18;53(2):127-30. doi: 10.1007/BF00426481.
8
[Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].[五种长效抗精神病药物的临床研究。癸酸氟奋乃静、氟斯必林、五氟利多、庚酸奋乃静和棕榈酸哌泊噻嗪的疗效对比]
Arzneimittelforschung. 1975 Feb;25(2):267-70.
9
[Paranoid psychosis in acute intermittent porphyria treated with perphenazine].[用奋乃静治疗急性间歇性卟啉病所致的偏执型精神病]
Ugeskr Laeger. 1998 Nov 2;160(45):6529-31.
10
[Perphenazine enantate in long-term therapy of psychoses].[奋乃静庚酸酯在精神病长期治疗中的应用]
Nord Psykiatr Tidsskr. 1968;22(4):358-60. doi: 10.3109/08039486809097994.

引用本文的文献

1
Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.抗精神病药物。血浆浓度监测潜在候选药物的临床药代动力学。
Clin Pharmacokinet. 1987 Aug;13(2):65-90. doi: 10.2165/00003088-198713020-00001.
2
Clinical pharmacokinetic studies of perphenazine.奋乃静的临床药代动力学研究。
Br J Clin Pharmacol. 1976 Oct;3(5):915-23. doi: 10.1111/j.1365-2125.1976.tb00647.x.
3
Measurement of plasma levels of tricylic psychoactive drugs and their metabolites by UV reflectance photometry of thin layer chromatograms.

本文引用的文献

1
THIORIDAZINE BLOOD LEVELS IN PATIENTS RECEIVING DIFFERENT ORAL FORMS.
Clin Pharmacol Ther. 1965 Jul-Aug;6:486-91. doi: 10.1002/cpt196564486.
2
PERPHENAZINE (TRILAFON) METABOLISM IN PSYCHOTIC PATIENTS.
Arch Gen Psychiatry. 1964 Jun;10:639-46. doi: 10.1001/archpsyc.1964.01720240093010.
3
PERPHENAZINE: A REAPPRAISAL AFTER EIGHT YEARS.奋乃静：八年后的重新评估。
Dis Nerv Syst. 1964 May;25:311-8.
4
通过薄层色谱图的紫外反射光度法测量三环类精神活性药物及其代谢物的血浆水平。
Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):457-65. doi: 10.1007/BF00606565.
4
Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline.
Eur J Clin Pharmacol. 1977 Jul 19;11(6):479-83. doi: 10.1007/BF00562943.
5
Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs.在与抗胆碱能药物同时治疗期间奋乃静及其主要代谢物的血浆水平。
Br J Clin Pharmacol. 1979 Jan;7(1):75-80. doi: 10.1111/j.1365-2125.1979.tb00900.x.
6
Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.连续口服治疗期间奋乃静及其亚砜代谢物的血浆浓度。
Psychopharmacology (Berl). 1977 Jul 18;53(2):127-30. doi: 10.1007/BF00426481.
7
Plasma level monitoring of antipsychotic drugs.抗精神病药物的血药浓度监测
Clin Pharmacokinet. 1978 Jan-Feb;3(1):14-38. doi: 10.2165/00003088-197803010-00002.
Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector.
使用带有电子捕获检测器的气液色谱法测定血浆中纳克量的氯丙嗪及其一些代谢物。
Anal Chem. 1968 Jul;40(8):1251-5. doi: 10.1021/ac60264a031.
5
Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.氯丙嗪：血浆浓度、尿排泄及作用持续时间。
Proc R Soc Med. 1971 Mar;64(3):285-9. doi: 10.1177/003591577106400323.
6
Urinary excretion of perphenazine and its sulfoxide during administration in oral and long-acting injectable form.口服及长效注射剂型给药期间奋乃静及其亚砜的尿排泄情况。
Psychopharmacologia. 1971;21(3):283-6. doi: 10.1007/BF00403866.
7
Determination of perphenazine and fluphenazine in whole blood by gas chromatography.
Med Lab Technol. 1973 Apr;30(2):129-32.
8
Effects of mode of management on plasma chlorpromazine in psychiatric patients.管理方式对精神科患者血浆氯丙嗪的影响。
Clin Pharmacol Ther. 1973 Nov-Dec;14(6):978-86. doi: 10.1002/cpt1973146978.
9
Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
J Med. 1972;3(3):146-62.
10
Determination of phenothiazine compounds in biologic specimens by UV spectrophotometry.
J Pharm Sci. 1971 Sep;60(9):1346-50. doi: 10.1002/jps.2600600912.